Literature DB >> 21638017

Soy protein diet and exercise training increase relative bone volume and enhance bone microarchitecture in a mouse model of uremia.

Emily J Tomayko1, Hae R Chung, Kenneth R Wilund.   

Abstract

Soy protein consumption and exercise training have been widely studied for their effects on the vasculature and bone in healthy populations, but little is known about the effectiveness of these interventions in chronic kidney disease (CKD). Cardiovascular disease and bone fracture risk are significantly elevated in CKD, and current pharmacological interventions have been unsuccessful in treating these conditions simultaneously. The purpose of this study was to compare the effects of a soy protein diet and endurance exercise training, alone or in combination, on cardiovascular and bone health in a mouse model of renal insufficiency. At 8 weeks of age, 60 female apolipoprotein E(-/-) mice underwent a two-step surgical procedure to induce uremia. These mice were then randomized at 12 weeks of age to one of four treatment groups for the 16-week intervention period: sedentary, control diet (n = 16); sedentary, soy protein diet (n = 18); exercise, control diet (n = 14); and exercise, soy protein diet (n = 12). There were no significant treatment effects on atherosclerotic lesion areas or aortic calcium deposits. We demonstrated a significant main effect of both diet and exercise on relative bone volume, trabecular number, trabecular separation, and trabecular connective density in the proximal femur as measured by microcomputed tomography. There were no treatment effects on trabecular thickness. We also showed a main effect of diet on plasma urea levels. These data suggest that soy protein intake and exercise training exert beneficial effects on properties of bone and plasma urea levels in mice with surgically induced renal impairment. © The Japanese Society for Bone and Mineral Research and Springer 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21638017     DOI: 10.1007/s00774-011-0278-4

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  48 in total

1.  Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee.

Authors:  Frank M Sacks; Alice Lichtenstein; Linda Van Horn; William Harris; Penny Kris-Etherton; Mary Winston
Journal:  Circulation       Date:  2006-01-17       Impact factor: 29.690

Review 2.  Reducing the burden of cardiovascular calcification in patients with chronic kidney disease.

Authors:  Wajeh Y Qunibi
Journal:  J Am Soc Nephrol       Date:  2005-11       Impact factor: 10.121

3.  Risk factors for hip fracture among patients with end-stage renal disease.

Authors:  C O Stehman-Breen; D J Sherrard; A M Alem; D L Gillen; S R Heckbert; C S Wong; A Ball; N S Weiss
Journal:  Kidney Int       Date:  2000-11       Impact factor: 10.612

4.  Oxygen consumption in adult and AGED C57BL/6J mice during acute treadmill exercise of different intensity.

Authors:  V Schefer; M I Talan
Journal:  Exp Gerontol       Date:  1996 May-Jun       Impact factor: 4.032

5.  Safety and antioxidant effects of a modest soy protein intervention in hemodialysis patients.

Authors:  Kristina Siefker; Robert A DiSilvestro
Journal:  J Med Food       Date:  2006       Impact factor: 2.786

6.  Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice.

Authors:  Olivier Phan; Ognen Ivanovski; Thao Nguyen-Khoa; Nadya Mothu; Jesus Angulo; Ralf Westenfeld; Markus Ketteler; Natalie Meert; Julien Maizel; Igor G Nikolov; Raymond Vanholder; Bernard Lacour; Tilman B Drüeke; Ziad A Massy
Journal:  Circulation       Date:  2005-11-01       Impact factor: 29.690

7.  Fetuin-A as a risk factor for mortality in hemodialysis patients.

Authors:  Breda Pecovnik Balon; Masa Knehtl; Sebastjan Bevc; Eva Jakopin; Maksimiljan Gorenjak
Journal:  Wien Klin Wochenschr       Date:  2010-05       Impact factor: 1.704

8.  Improving global outcomes in mineral and bone disorders.

Authors:  Sharon M Moe; Tilman Drüeke
Journal:  Clin J Am Soc Nephrol       Date:  2008-11       Impact factor: 8.237

Review 9.  Phytoestrogens in clinical practice: a review of the literature.

Authors:  Clemens B Tempfer; Eva-Katrin Bentz; Sepp Leodolter; Georg Tscherne; Ferdinand Reuss; Heide S Cross; Johannes C Huber
Journal:  Fertil Steril       Date:  2007-05-09       Impact factor: 7.329

Review 10.  Molecular, endocrine, and genetic mechanisms of arterial calcification.

Authors:  Terence M Doherty; Lorraine A Fitzpatrick; Daisuke Inoue; Jian-Hua Qiao; Michael C Fishbein; Robert C Detrano; Prediman K Shah; Tripathi B Rajavashisth
Journal:  Endocr Rev       Date:  2004-08       Impact factor: 19.871

View more
  1 in total

1.  Voluntary Wheel Running Has Beneficial Effects in a Rat Model of CKD-Mineral Bone Disorder (CKD-MBD).

Authors:  Keith G Avin; Matthew R Allen; Neal X Chen; Shruthi Srinivasan; Kalisha D O'Neill; Ashley D Troutman; Garrison Mast; Elizabeth A Swallow; Mary Beth Brown; Joseph M Wallace; Teresa A Zimmers; Stuart J Warden; Sharon M Moe
Journal:  J Am Soc Nephrol       Date:  2019-09-09       Impact factor: 14.978

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.